Literature DB >> 17165728

Diphosphiranium (P2C) or diphosphetanium (P2C2) cyclic cations: different fates for the electrophile-initiated cyclodimerization of a phosphaalkene.

Joshua I Bates1, Derek P Gates.   

Abstract

The synthesis and crystallographic characterization of two new classes of cationic three- and four-membered organophosphorus heterocycles are reported. Treating phosphaalkene tBuP=CHtBu (1) with triflic acid (2:1) afforded an unprecedented asymmetric diphosphiranium triflate [tBuP-CH(tBu)-P(tBu)(CH2tBu)]OTf (2). Surprisingly, the analogous reaction of tBuP=CHtBu with methyl triflate (2:1) afforded a 1,3-diphosphetanium salt [tBu(Me)P-CH(tBu)-P(tBu)-CH(tBu)]OTf (3a). Structural characterization of these novel P2C and P2C2 rings confirmed their identity, and the metrical parameters were consistent with the strain expected for these ring systems. In preliminary mechanistic investigations by NMR spectroscopy, phosphenium species [tBuPCH2tBu]OTf (4) was detected in the stoichiometric reaction of 1 with HOTf while methylenephosphonium [Me(tBu)P=CHtBu]OTf (5) was observed when 1 was treated with MeOTf. The opposite reactivity observed when the P=C bond is treated with MeOTf compared that with HOTf is surprising and, to our knowledge, has not been observed previously in phosphaalkene chemistry. In addition to their fundamental interest, we are interested in these species as ring-closed forms of the propagating species in the cationic polymerization of P=C bonds.

Entities:  

Year:  2006        PMID: 17165728     DOI: 10.1021/ja0667662

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  1 in total

1.  E-Selective Synthesis and Coordination Chemistry of Pyridine-Phosphaalkenes: Five Ligands Produce Four Distinct Types of Ru(II) Complexes.

Authors:  Mika L Nakashige; Jarin I P Loristo; Lesley S Wong; Joshua R Gurr; Timothy J O'Donnell; Wesley Y Yoshida; Arnold L Rheingold; Russell P Hughes; Matthew F Cain
Journal:  Organometallics       Date:  2019-08-22       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.